Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: MAC stock price vs IOVA: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at IOVA's multiple
Needs IOVA P/S.
Implied fair value · at MAC's multiple
Needs MAC P/S.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: MAC FY 2025 (ended Dec 31, 2025) · IOVA FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
MACERICH CO · implied price per share
Bear
-$7.22
Base
-$8.50
Bull
-$9.77
IOVANCE BIOTHERAPEUTICS, INC. · implied price per share
Bear
-$0.65
Base
-$0.77
Bull
-$0.88
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
2.07x
0.00x
Net debt / EBITDA
Leverage against operating earnings
16.24x
0.85x
Cash and equivalents
Liquid reserves on the balance sheet
$280.25M
$296.98M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
SIMON PROPERTY GROUP INC /DE/
MAC vs SPG
KIMCO REALTY CORP
MAC vs KIM
Brixmor Property Group Inc.
MAC vs BRX
REGENCY CENTERS CORP
MAC vs REG
FEDERAL REALTY INVESTMENT TRUST
MAC vs FRT
BioNTech SE
MAC vs BNTX
Moderna, Inc.
MAC vs MRNA
GILEAD SCIENCES, INC.
MAC vs GILD
Legend Biotech Corp
MAC vs LEGN
$5.07B
$1.00M
Live quote
Edwyn research
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
